Farallon Capital Management, L.L.C.
SAN FRANCISCO, CA
$16.9bn in 82 US stocks at the end of 30 June 2026. The top 10 are 56.2% of the money. It changed about 25.1% of the portfolio this quarter.
Value
$16.9bn
Stocks
82
Top 10 share
56.2%
Turnover
25.1%
What changed this quarter
New
Bought for the first time this quarter.
- Parabilis MedicinesPBLS0.4% of the fund
- Novartis AGNVS0.3% of the fund
- Warby ParkerWRBY0.1% of the fund
- Kailera TherapeuticsKLRA0.1% of the fund
- Axalta Coating SystemsAXTA<0.1% of the fund
- BiogenBIIB<0.1% of the fund
- Taysha Gene TherapiesTSHA<0.1% of the fund
- Mobia MedicalMOBI<0.1% of the fund
- Alamar BiosciencesALMR<0.1% of the fund
- InflaRxIFRX<0.1% of the fund
- Scotts Miracle-GroSMG<0.1% of the fund
- Waystar HoldingWAY<0.1% of the fund
- BrunswickBC<0.1% of the fund
- GentexGNTX<0.1% of the fund
- Idexx LaboratoriesIDXX<0.1% of the fund
- Commercial MetalsCMC<0.1% of the fund
- JATT II AcquisitionJATT<0.1% of the fund
- Sagimet BiosciencesSGMT<0.1% of the fund
Added
Bought more of a stock they already held.
- Electronic ArtsEA9.6% of the fund+6%
- BridgeBio PharmaBBIO4.7% of the fund+15%
- ExelixisEXEL4.3% of the fund+3%
- Thermo Fisher ScientificTMO3.1% of the fund+19%
- Roivant SciencesROIV3.0% of the fund+48%
- Boston ScientificBSX2.7% of the fund+41%
- Tango TherapeuticsTNGX2.3% of the fund+35%
- Crinetics PharmaceuticalsCRNX2.0% of the fund+8%
- GrailGRAL1.7% of the fund+28%
- ImmunovantIMVT1.3% of the fund+275%
- Twist BioscienceTWST1.3% of the fund+50%
- Agios PharmaceuticalsAGIO1.3% of the fund+4%
- BaiduBIDU0.8% of the fund+171%
- Novo Nordisk A SNVO0.7% of the fund+235%
- Acadia Healthcare CompanyACHC0.7% of the fund+143%
- BrightSpring Health ServicesBTSG0.7% of the fund+7%
- AstrazenecaAZN0.6% of the fund+153%
- Johnson & JohnsonJNJ0.6% of the fund+176%
- Guardant HealthGH0.3% of the fund+3928%
- Avalo TherapeuticsAVTX0.3% of the fund+173%
- JoyyJOYY0.3% of the fund+21%
- Assembly BiosciencesASMB0.3% of the fund+31%
- Maze TherapeuticsMAZE0.2% of the fund+197%
- Rio TintoRIO0.1% of the fund+241%
- Abivax SAABVX<0.1% of the fund+6000%
Cut
Sold some of their stake.
- LiquidiaLQDA3.9% of the fund-3%
- Amazon.comAMZN3.7% of the fund-38%
- NateraNTRA3.6% of the fund-31%
- UnitedHealth GroupUNH3.1% of the fund-30%
- AonAON2.7% of the fund-45%
- BroadcomAVGO2.6% of the fund-35%
- MicrosoftMSFT2.4% of the fund-53%
- KKRKKR2.2% of the fund-12%
- SynopsysSNPS2.2% of the fund-32%
- Westinghouse Air Brake TechnologiesWAB1.4% of the fund-44%
- AramarkARMK1.2% of the fund-41%
- Enanta PharmaceuticalsENTA0.2% of the fund-16%
- MerckMRK0.2% of the fund-45%
- Netease.comNTES<0.1% of the fund-58%
- Beta BionicsBBNX<0.1% of the fund-84%
- Teva Pharmaceutical IndustriesTEVA<0.1% of the fund-89%
- WelltowerWELL<0.1% of the fund-100%
- Blue GoldBGLWW<0.1% of the fund-15%
- Pacific Biosciences of CaliforniaPACB<0.1% of the fund-89%
- GeronGERN<0.1% of the fund-67%
- Canopy GrowthCGC<0.1% of the fund-40%
- Rani Therapeutics HoldingsRANI<0.1% of the fund-73%
Sold out
Sold their entire stake.
- Charles SchwabSCHW-100%
- AlphabetGOOG-100%
- VisaV-100%
- Walt DisneyDIS-100%
- MastercardMA-100%
- MckessonMCK-100%
- Centessa Pharmaceuticals-100%
- Tyra BiosciencesTYRA-100%
- Tenet HealthcareTHC-100%
- Cardinal HealthCAH-100%
- VaxcytePCVX-100%
- Dianthus TherapeuticsDNTH-100%
- CG OncologyCGON-100%
- Bitwise 10 Crypto Index ETFBITW-100%
- Royalty PharmaRPRX-100%
- Ceco EnvironmentalCECO-100%
- GDS HldgsGDS-100%
- FormfactorFORM-100%
- MastecMTZ-100%
- EntegrisENTG-100%
- CitigroupC-100%
- Hyatt HotelsH-100%
- Western Alliance BancorporationWAL-100%
- TimkenTKR-100%
- FlexFLEX-100%
Holdings
- Electronic ArtsEA
- Share
- 9.6%
- Value
- $1.6bn
- Shares
- 7,919,500
+6%
- Crinetics PharmaceuticalsCRNX
- Share
- 2.0%
- Value
- $336m
- Shares
- 8,989,098
+8%
- BaiduBIDU
- Share
- 0.8%
- Value
- $138m
- Shares
- 1,203,785
+171%
- Parabilis MedicinesPBLS
- Share
- 0.4%
- Value
- $65m
- Shares
- 2,368,200
New
- JoyyJOYY
- Share
- 0.3%
- Value
- $46m
- Shares
- 699,200
+21%
- Kailera TherapeuticsKLRA
- Share
- 0.1%
- Value
- $24m
- Shares
- 1,100,000
New
- Abivax SAABVX
- Share
- <0.1%
- Value
- $16m
- Shares
- 122,000
+6000%
- Vnet GroupVNET
- Share
- <0.1%
- Value
- $16m
- Shares
- 1,992,000
+220%
- Netease.comNTES
- Share
- <0.1%
- Value
- $16m
- Shares
- 123,500
-58%
- Mobia MedicalMOBI
- Share
- <0.1%
- Value
- $15m
- Shares
- 1,128,557
New
- Alamar BiosciencesALMR
- Share
- <0.1%
- Value
- $13m
- Shares
- 462,900
New
- JATT II AcquisitionJATT
- Share
- <0.1%
- Value
- $3m
- Shares
- 300,000
New
- Revolution MedicinesRVMDW
- Share
- <0.1%
- Value
- $1m
- Shares
- 120,085
Held
- AleannaANNAW
- Share
- <0.1%
- Value
- $297,000
- Shares
- 990,000
Held
- Solid PowerSLDPW
- Share
- <0.1%
- Value
- $41,423
- Shares
- 405,316
Held
- Blue GoldBGLWW
- Share
- <0.1%
- Value
- $30,696
- Shares
- 255,800
-15%
- Nvni Group LimitedNVNIW
- Share
- <0.1%
- Value
- $17,550
- Shares
- 375,000
Held
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Revolution MedicinesRVMD | 15.0% | $2.5bn | 13,550,796 | Held |
| Electronic ArtsEA | 9.6% | $1.6bn | 7,919,500 | +6% |
| BridgeBio PharmaBBIO | 4.7% | $800m | 10,743,063 | +15% |
| Protagonist TherapeuticsPTGX | 4.6% | $778m | 6,348,906 | Held |
| ExelixisEXEL | 4.3% | $733m | 13,468,010 | +3% |
| LiquidiaLQDA | 3.9% | $667m | 8,365,038 | -3% |
| Amazon.comAMZN | 3.7% | $628m | 2,632,994 | -38% |
| Lantheus HoldingsLNTH | 3.7% | $619m | 5,583,479 | Held |
| NateraNTRA | 3.6% | $602m | 2,218,366 | -31% |
| UnitedHealth GroupUNH | 3.1% | $528m | 1,270,532 | -30% |
| Thermo Fisher ScientificTMO | 3.1% | $526m | 1,049,185 | +19% |
| Roivant SciencesROIV | 3.0% | $506m | 14,309,000 | +48% |
| AonAON | 2.7% | $459m | 1,382,562 | -45% |
| Boston ScientificBSX | 2.7% | $449m | 10,521,184 | +41% |
| BroadcomAVGO | 2.6% | $435m | 1,151,800 | -35% |
| MicrosoftMSFT | 2.4% | $415m | 1,112,863 | -53% |
| Tango TherapeuticsTNGX | 2.3% | $384m | 12,277,000 | +35% |
| KKRKKR | 2.2% | $378m | 4,118,300 | -12% |
| SynopsysSNPS | 2.2% | $370m | 829,600 | -32% |
| Beam TherapeuticsBEAM | 2.1% | $351m | 10,236,396 | Held |
| Crinetics PharmaceuticalsCRNX | 2.0% | $336m | 8,989,098 | +8% |
| GrailGRAL | 1.7% | $284m | 4,161,584 | +28% |
| Westinghouse Air Brake TechnologiesWAB | 1.4% | $241m | 894,503 | -44% |
| ImmunovantIMVT | 1.3% | $224m | 5,805,000 | +275% |
| Twist BioscienceTWST | 1.3% | $220m | 2,136,400 | +50% |
| Agios PharmaceuticalsAGIO | 1.3% | $220m | 5,917,400 | +4% |
| AramarkARMK | 1.2% | $206m | 3,625,731 | -41% |
| BaiduBIDU | 0.8% | $138m | 1,203,785 | +171% |
| Novo Nordisk A SNVO | 0.7% | $126m | 2,619,000 | +235% |
| Acadia Healthcare CompanyACHC | 0.7% | $125m | 4,220,800 | +143% |
| BrightSpring Health ServicesBTSG | 0.7% | $121m | 1,732,800 | +7% |
| AstrazenecaAZN | 0.6% | $109m | 574,000 | +153% |
| Johnson & JohnsonJNJ | 0.6% | $104m | 408,000 | +176% |
| Parabilis MedicinesPBLS | 0.4% | $65m | 2,368,200 | New |
| Novartis AGNVS | 0.3% | $57m | 363,000 | New |
| Guardant HealthGH | 0.3% | $48m | 322,200 | +3928% |
| Avalo TherapeuticsAVTX | 0.3% | $46m | 2,498,000 | +173% |
| JoyyJOYY | 0.3% | $46m | 699,200 | +21% |
| Assembly BiosciencesASMB | 0.3% | $44m | 1,604,590 | +31% |
| Enanta PharmaceuticalsENTA | 0.2% | $35m | 2,418,202 | -16% |
| Maze TherapeuticsMAZE | 0.2% | $33m | 1,107,814 | +197% |
| MerckMRK | 0.2% | $26m | 199,000 | -45% |
| Warby ParkerWRBY | 0.1% | $25m | 828,000 | New |
| FreenomeFRNM | 0.1% | $24m | 2,250,000 | Held |
| Kailera TherapeuticsKLRA | 0.1% | $24m | 1,100,000 | New |
| Rio TintoRIO | 0.1% | $17m | 183,475 | +241% |
| Axalta Coating SystemsAXTA | <0.1% | $16m | 478,000 | New |
| Abivax SAABVX | <0.1% | $16m | 122,000 | +6000% |
| Vnet GroupVNET | <0.1% | $16m | 1,992,000 | +220% |
| Netease.comNTES | <0.1% | $16m | 123,500 | -58% |
| BiogenBIIB | <0.1% | $15m | 71,000 | New |
| Taysha Gene TherapiesTSHA | <0.1% | $15m | 2,250,000 | New |
| Mobia MedicalMOBI | <0.1% | $15m | 1,128,557 | New |
| Minerva NeurosciencesNERV | <0.1% | $13m | 2,365,000 | Held |
| Alamar BiosciencesALMR | <0.1% | $13m | 462,900 | New |
| AlvotechALVO | <0.1% | $11m | 2,859,675 | +1332% |
| Beta BionicsBBNX | <0.1% | $9m | 595,000 | -84% |
| InflaRxIFRX | <0.1% | $7m | 3,325,000 | New |
| Scotts Miracle-GroSMG | <0.1% | $6m | 88,000 | New |
| Waystar HoldingWAY | <0.1% | $5m | 264,900 | New |
| BrunswickBC | <0.1% | $5m | 61,000 | New |
| GentexGNTX | <0.1% | $5m | 199,000 | New |
| Idexx LaboratoriesIDXX | <0.1% | $5m | 9,000 | New |
| Prime MedicinePRME | <0.1% | $5m | 1,240,843 | Held |
| Commercial MetalsCMC | <0.1% | $4m | 67,000 | New |
| JATT II AcquisitionJATT | <0.1% | $3m | 300,000 | New |
| Sagimet BiosciencesSGMT | <0.1% | $3m | 415,000 | New |
| Summit MidstreamSMC | <0.1% | $2m | 58,214 | Held |
| Teva Pharmaceutical IndustriesTEVA | <0.1% | $1m | 40,000 | -89% |
| Revolution MedicinesRVMDW | <0.1% | $1m | 120,085 | Held |
| Cogent BiosciencesCOGT | <0.1% | $657,900 | 17,000 | Held |
| AleannaANNAW | <0.1% | $297,000 | 990,000 | Held |
| AleAnnaANNA | <0.1% | $227,360 | 78,400 | Held |
| WelltowerWELL | <0.1% | $226,970 | 1,000 | -100% |
| Solid PowerSLDPW | <0.1% | $41,423 | 405,316 | Held |
| Blue GoldBGLWW | <0.1% | $30,696 | 255,800 | -15% |
| Pacific Biosciences of CaliforniaPACB | <0.1% | $23,856 | 14,200 | -89% |
| GeronGERN | <0.1% | $18,432 | 14,400 | -67% |
| Nvni Group LimitedNVNIW | <0.1% | $17,550 | 375,000 | Held |
| Canopy GrowthCGC | <0.1% | $17,100 | 18,000 | -40% |
| Rani Therapeutics HoldingsRANI | <0.1% | $15,740 | 20,700 | -73% |
| Beyond MeatBYND | <0.1% | $14,250 | 19,000 | Held |
Options (3)
- State STR Spdr S&P 500 ETF TSPY
- Type
- Put
- Value
- $4.5bn
- Contracts
- 6,000,000
- Ishares TRSOXX
- Type
- Put
- Value
- $83m
- Contracts
- 130,000
- CG OncologyCGON
- Type
- Call
- Value
- $28m
- Contracts
- 400,000
| Company | Type | Value | Contracts |
|---|---|---|---|
| State STR Spdr S&P 500 ETF TSPY | Put | $4.5bn | 6,000,000 |
| Ishares TRSOXX | Put | $83m | 130,000 |
| CG OncologyCGON | Call | $28m | 400,000 |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is down 22.6% since 30 June 2025.
Where the money is
Health care70.2%
Technology16.8%
Retail & consumer5.0%
Financial services5.0%
Industrials1.4%
Materials0.3%
Utilities0.0%
Energy0.0%
Real estate0.0%
Everyday goods0.0%
Other1.4%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.